Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

(1,408)(1,413)Deferred revenue

(83,107)(2,722)Other liabilities

(2,049)(2,823)Net cash used in operating activities

$ (76,278)$   (90,453)Cash flows from investing activities:Purchases of investments

(315,160)(298,054)Sales of investments

10,29011,923Maturities of investments

360,906266,202Transaction costs from Novartis pulmonary asset sale

-(4,440)Purchases of property and equipment

(22,160)(10,763)Net cash provided by investing activities

$  33,876$   (35,132)Cash flows from financing activities:Payments of loan and capital lease obligations

(1,119)(935)Proceeds from issuances of common stock

7,1423,821Net cash provided by financing activities

$
,023$
2,886Effect of exchange rates on cash and cash equivalents

(312)(108)Net decrease in cash and cash equivalents

$ (36,691)$ (122,807)Cash and cash equivalents at beginning of period

49,597155,584Cash and cash equivalents at end of period

$  12,906$
32,777
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 Following the ... Legal Action Center (LAC) released a report today ... growing opioid and heroin epidemic through more effective ... The report, "The Case for Expanding Access to ... Epidemic," outlines the health, justice, and economic advantages ...
(Date:3/4/2015)... 2015  Kannalife Sciences, Inc. ("Kannalife") announces that Dr. ... Advisory Board to assist the Company in the advancement ... of cannabinoid therapeutics for the treatment of Chronic Traumatic ... for conducting the full autopsy of Mike Webster ... the Pittsburgh Steelers. It was through his examination of ...
(Date:3/4/2015)... , March 4, 2015  Students from Indiana ... at how new medicines are discovered. Through a partnership ... fourth-year medical students from IU School of Medicine are ... working at Lilly play different and important roles in ... "As a former medical educator, scientific investigator, and health ...
Breaking Medicine Technology:Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 3Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Columbus is no ... steady prevalence of cocaine addiction, and suffers from the ... on Feb. 27th, the DEA revealed that Kratom is ... a herbal tea; the newly introduced herb from Southeast Asia ... in heightened doses. WKYC notes kratom foments symptoms similar to ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously ... Visiopharm Board of Directors as Chairman. ... are positioned to become the fastest growing software company, ... research. , "Over the last several years, ... of ONCOtopix™ Dx, a complete quantitative digital pathology solution ...
(Date:3/4/2015)... Follow us on LinkedIn – ... increasing incidence of CNS disorders, aging population, rising healthcare ... The unmet medical needs for diagnosing and treating CNS ... market. Presently, there exists an urgent need for developing ... current generation drugs. Companies are therefore investing to develop ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4
... Patients with a specific kind of lung cancer may benefit ... UCSD Cancer Center. The new drug, crizotinib, under development by ... some patients during Phase I and II clinical trials. ... encouraging," said Lyudmila Bazhenova, MD, assistant clinical professor at UC ...
... ... RE/MAX agent who participates in the “Home for the Cure™” program, through ... for the Cure when a home sale is complete. The newly rebranded ... signs, is meant to raise money for breast cancer research, education and ...
... St. Gregory Retreat ... Health Program. , ... 22, 2010 -- St Gregory Centers, Inc. announced today that they have signed agreements with ... employees. The Mayo Clinic program will be an integral part of St Gregory’s Life ...
... to be published on 21 June 2010 in the ... (Inserm unit 625 Research Group on Human and ... Hospital Centre) in Pointe Pitre (urology department, University ... the Center for Analytical Research and Technology (University of ...
... Researchers at the Oregon Health & Science University ... bioluminescence a way of measuring visible light generated from ... rapidly assessing in children at the chair-side the number of ... to tooth decay. The study is published ...
... ... to young women. They promote thinness at all costs and often disregard ... Journal of Public Health published a recent study of Pro Ana websites. This ... Stanford University School of Medicine, has raised questions about how we can meet ...
Cached Medicine News:Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 2Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 3Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 4Health News:St. Gregory Centers, Inc. Announces Integrating Mayo Clinic Health Wellness Program 2Health News:Chlordecone exposure and risk of prostate cancer 2Health News:OHSU School of Dentistry team examines how to rapily assess children's tooth decay risk 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 3
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
Curved tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
Thornton titanium curved suture tying forceps, 4"....
Medicine Products: